Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2âNegative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel.

Mahtani, Reshma; Niyazov, Alexander; Arondekar, Bhakti; Lewis, Katie; Rider, Alex; Massey, Lucy; Lux, Michael Patrick

Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2âNegative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel.

Mahtani, Reshma; Niyazov, Alexander; Arondekar, Bhakti; Lewis, Katie; Rider, Alex; Massey, Lucy; Lux, Michael Patrick.

Afiliación

Mahtani R; Miami Cancer Institute, 1228 S Pine Island Road, Plantation, FL, 33324, USA. Electronic address: rmahtani@baptisthealth.net.
Niyazov A; Pfizer Inc, 235 42nd St, New York, NY, 10017, USA. Electronic address: Alexander.Niyazov@pfizer.com.
Arondekar B; Pfizer Inc, 500 Arcola Rd, Collegeville, PA, 19426, USA. Electronic address: Bhakti.Arondekar@pfizer.com.
Lewis K; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Cheshire, SK10 5JB, UK. Electronic address: katie.lewis@adelphigroup.com.
Rider A; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Cheshire, SK10 5JB, UK. Electronic address: Alex.Rider@adelphigroup.com.
Massey L; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Cheshire, SK10 5JB, UK. Electronic address: lucy.massey@adelphigroup.com.
Lux MP; Kooperatives Brustzentrum Paderborn, Frauenklinik St. Louise, Paderborn, Frauenklinik St. Josefs, Salzkotten Husener Straße 81, 33098, Paderborn, Germany. Electronic address: M.Lux@vincenz.de.

Breast ; 66: 236-244, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36368161

Asunto(s)

Neoplasias de la Mama; Médicos; Neoplasias de la Mama Triple Negativas; Humanos; Estados Unidos; Adolescente; Adulto; Persona de Mediana Edad; Femenino; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/genética; Neoplasias de la Mama/metabolismo; Neoplasias de la Mama Triple Negativas/tratamiento farmacológico; Estudios Retrospectivos; Israel; Satisfacción del Paciente; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Receptor ErbB-2/genética; Receptor ErbB-2/metabolismo; Demografía; Proteína BRCA1/genética

Palabras clave

Breast cancer susceptibility gene 1 or 2; Hereditary breast cancer; Real-world; Safety; Treatment patterns; poly(adenosine diphosphate-ribose) polymerase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médicos / Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Guideline / Qualitative_research Límite: Adolescent / Adult / Female / Humans / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google